Klaus Hirschbühl
- Infectious Diseases top 5%
- Neurology top 5%
- Oncology
- Pulmonary and Respiratory Medicine
- Critical Care and Intensive Care Medicine top 10%
- Co-authors
- Bruno MärklTina SchallerRainer ClausKatrin BurkhardtMartin TrepelGeorg BraunKatharina EndhardtChristine Dhillon
- Topics
- SARS-CoV-2 and COVID-19 Research (5 papers)COVID-19 Clinical Research Studies (5 papers)Acute Myeloid Leukemia Research (3 papers)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Klaus Hirschbühl
14 papers receiving 479 citations
Hit Papers
Peers
Comparison fields: 5 of 59
- Infectious Diseases 324
- Neurology 204
- Oncology 116
- Pulmonary and Respiratory Medicine 70
- Critical Care and Intensive Care Medicine 44
Countries citing papers authored by Klaus Hirschbühl
This map shows the geographic impact of Klaus Hirschbühl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Hirschbühl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Hirschbühl more than expected).
Fields of papers citing papers by Klaus Hirschbühl
This network shows the impact of papers produced by Klaus Hirschbühl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Hirschbühl. The network helps show where Klaus Hirschbühl may publish in the future.
Co-authorship network of co-authors of Klaus Hirschbühl
This figure shows the co-authorship network connecting the top 25 collaborators of Klaus Hirschbühl. A scholar is included among the top collaborators of Klaus Hirschbühl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus Hirschbühl. Klaus Hirschbühl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 3 | |
| 3 | 0 | |
| 4 | 13 | |
| 5 | 0 | |
| 6 | 3 | |
| 7 | 3 | |
| 8 | 1 | |
| 9 | 16 | |
| 10 | 9 | |
| 11 | 3 | |
| 12 | 14 | |
| 13 | Postmortem Examination of Patients With COVID-19breakdown → | 375 |
| 14 | 1 | |
| 15 | 13 | |
| 16 | 30 |
About Klaus Hirschbühl
Klaus Hirschbühl is a scholar working on Hematology, Infectious Diseases and Neurology, having authored 16 papers that have together received 487 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 Clinical Research Studies (5 papers) and Acute Myeloid Leukemia Research (3 papers). The work is most often cited by research in Infectious Diseases (324 citations), Neurology (204 citations) and Critical Care and Intensive Care Medicine (44 citations). Klaus Hirschbühl has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Bruno Märkl, Tina Schaller, Rainer Claus, Katrin Burkhardt, Martin Trepel, Georg Braun, Katharina Endhardt, Christine Dhillon, Gerhard Schenkirsch and Sebastian Dintner. Their work appears in journals such as JAMA, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.